Wellinks
Convexity Scientific Inc.
Discover Wellinks' innovative pulmonary rehabilitation programs. Improve lung health with personalized, virtual care for COPD. Start your journey to better breathing today!
wellinks.com · New Haven, CT
Funding event
The round itself, as filedInferred stageSeries A
Sold of offered$10.0M of $13.0M
Filed2026-08-07
Days since filing58
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2026-07-23
Investors
No investors named: Form D does not list them
This round was amended. Amendment filing
Officers on the filing
Names and roles as filed; addresses are never stored- Jennifer BarrettaExecutive Officer
- Kevin RakinDirector
- Henry WeinsteinDirector
- Stephen BrusoDirector
- Mike WatersDirector
- Andrew AgwunobiDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged93.6% sold2.4 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedFlaggedD/A on 2026-08-07amount offered changed from $13.0M
Open roles
On the employer's own careers page · checked 2026-09-242
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
- Senior Data and BI AnalystSEP 25Remote (United States) · 302 Engineering · open 9 days
- Technical Product ManagerSEP 25Remote (United States) · 302 Engineering · open 9 days
All filings
Every filing for this company, newest first, amendments includedAlso raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-03, against 71 in the 28 days before.